Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q94601377)
Watch
English
[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]
No description defined
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
review article
1 reference
stated in
Europe PubMed Central
title
[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
author name string
Jean-Pierre Valat
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
Gilbert Deray
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
François Héloire
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
language of work or name
French
0 references
publication date
1 September 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
published in
La Presse médicale
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
volume
35 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
page(s)
25-34
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
cites work
The coxibs, selective inhibitors of cyclooxygenase-2.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association between naproxen use and protection against acute myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective cyclooxygenase 2 inhibitors and cardiovascular events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relative thromboembolic risks associated with COX-2 inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-narcotic analgesic dose and risk of incident hypertension in US women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between COX-2 specific inhibitors and hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974937-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0755-4982(06)74937-5
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
PubMed ID
17870550
1 reference
stated in
Europe PubMed Central
PubMed ID
17870550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17870550%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 May 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit